ClinicalTrials.gov
public full text
Public Domain
Lacosamide Versus Topiramate in Migraine
Investigators aim to compare the effect of lacosamide versus topiramate in migraine by assessing the absolute reduction in MMD in each group, the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.#891989
- Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention#878126
- Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine#871227
- A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache#969356
- Predictive Role of MIDAS Reduction at 3 Months for Erenumab Treatment#827009
Record · ID 916844
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive